Biolife Solutions (BLFS) | Stock Overview & Key Data
Biolife Solutions Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $1,382.50 on November 4, 1991
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Biolife Solutions BLFS | 1.07B Small-cap | -1.85% | -6.33% | -2.02% | -16.08% | -14.71% | 8.83% | 41.73% | 15.35% |
| Intuitive Surgical ISRG | 189.74B Large-cap | -2.31% | 0.38% | 0.99% | -3.53% | 0.78% | 18.72% | 150.00% | 143.10% |
| Becton, Dickinson BDX | 50.00B Large-cap | -1.00% | 1.73% | -16.17% | -24.89% | -22.51% | -23.78% | -27.01% | -32.96% |
| Lemaitre Vascular LMAT | 1.90B Small-cap | 0.83% | 1.48% | 0.77% | -9.66% | -7.57% | -2.78% | 79.22% | 201.94% |
| AtriCure ATRC | 1.57B Small-cap | 1.69% | -6.61% | -3.56% | 1.62% | 5.00% | 36.39% | -27.70% | -31.79% |
| Azenta AZTA | 1.53B Small-cap | 1.58% | 13.97% | 12.70% | -35.45% | -33.31% | -37.56% | -49.13% | -25.71% |
Ownership & Short Interest
Biolife Solutions Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Biolife Solutions would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is BLFS's 52-week high and low?
In the last 52 weeks, Biolife Solutions reached a high of $29.55 (on January 30, 2025) and a low of $18.70 (on July 11, 2024).
What is the market cap and P/E ratio for BLFS?
Curious about Biolife Solutions's size and valuation? Its market capitalization stands at 1.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is -50.75, and the forward P/E (looking ahead) is -80.54.
Does BLFS pay dividends? If so, what's the yield?
As for dividends, Biolife Solutions isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Biolife Solutions's main competitors or similar companies to consider before investing?
When looking at Biolife Solutions, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Intuitive Surgical ISRG | 189.74B | Healthcare | Medical Instruments & Supplies | 18.72% | 150.00% |
| Becton, Dickinson BDX | 50.00B | Healthcare | Medical Instruments & Supplies | -23.78% | -27.01% |
| Lemaitre Vascular LMAT | 1.90B | Healthcare | Medical Instruments & Supplies | -2.78% | 79.22% |
| AtriCure ATRC | 1.57B | Healthcare | Medical Instruments & Supplies | 36.39% | -27.70% |
| Azenta AZTA | 1.53B | Healthcare | Medical Instruments & Supplies | -37.56% | -49.13% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Biolife Solutions Inc.? (e.g., ROE, Debt/Equity)
To get a sense of Biolife Solutions's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -2.52%, the Debt to Equity ratio from the most recent quarter is 7.64, and its Gross Profit Margin stands at 65.94%.
What is the recent revenue and earnings growth for BLFS?
Looking at Biolife Solutions's growth, its revenue over the trailing twelve months (TTM) was $88M. Compared to the same quarter last year (YoY), quarterly revenue grew by 29.90%, and quarterly earnings saw a YoY growth of -24.54%.
How much of BLFS stock is held by insiders and institutions?
Wondering who owns Biolife Solutions stock? Company insiders (like executives and directors) hold about 2.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 100.53%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.